Docoh
Loading...

ILMN Illumina

News

Pro users get this 30m faster
Ginkgo Bioworks, Which Prints DNA And Creates Genetically Modified Food, Exploring SPAC Deal: Report
9 Apr 21
M&A, News, IPOs
One of the largest SPACs seeking a target could be nearing a $20 billion deal to bring one of the largest privately-held biotechnology companies public.
51 Biggest Movers From Yesterday
7 Apr 21
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers UTime Limited (NASDAQ: UTME) shares jumped 875% to close at $39.00 on Tuesday after the company priced its IPO at $4 per share.
P/E Ratio Insights for Illumina
6 Apr 21
Earnings, News, Intraday Update, Markets
33 Stocks Moving In Tuesday's Mid-Day Session
6 Apr 21
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Gainers
Wells Fargo Maintains Underweight on Illumina, Raises Price Target to $330
6 Apr 21
News, Price Target, Analyst Ratings
Wells Fargo analyst Dan Leonard maintains Illumina (NASDAQ:ILMN) with a Underweight and raises the price target from $300 to $330.
Canaccord Genuity Maintains Buy on Illumina, Raises Price Target to $460
6 Apr 21
News, Price Target, Analyst Ratings
Canaccord Genuity maintains Illumina (NASDAQ:ILMN) with a Buy and raises the price target from $445 to $460.
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
6 Apr 21
Pre-Market Outlook, Markets, Movers
The Daily Biotech Pulse: Illumina Lights Up, Cara Soars On Index Inclusion, Novavax Starts Crossover Vaccine Study, Turning Point Data Readout
6 Apr 21
Biotech, Earnings, News, Penny Stocks, Guidance, Offerings, Small Cap, FDA
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 5)
20 Stocks Moving in Tuesday's Pre-Market Session
6 Apr 21
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers Brooklyn ImmunoTherapeutics, Inc. (NYSE: BTX) rose 60.6% to $7.50 in pre-market trading as multiple Form 3 filings late Monday showed new stakes by insiders.
A Peek Into The Markets: US Stock Futures Edge Lower Following Monday's Rally; Crude Oil Rises 2%
6 Apr 21
Earnings, News, Eurozone, Futures, Small Cap, Global, Pre-Market Outlook, Markets
Pre-open movers
5 Stocks To Watch For April 6, 2021
6 Apr 21
Earnings, News, Small Cap, Pre-Market Outlook, Markets, Trading Ideas
Some of the stocks that may grab investor focus today are:
Benzinga's Top Ratings Upgrades, Downgrades For March 31, 2021
31 Mar 21
Upgrades, Downgrades, Initiation, Intraday Update, Analyst Ratings
Looking Into Illumina's Return On Capital Employed
31 Mar 21
Earnings, News
Illumina (NASDAQ:ILMN) posted a 17.9% decrease in earnings from Q3. Sales, however, increased by 20.03% over the previous quarter to $953.00 million. Despite the increase in sales this quarter, the decrease in earnings may suggest Illumina is not utilizing their capital as effectively as possible.
Atlantic Equities Downgrades Illumina to Neutral, Announces $390 Price Target
31 Mar 21
News, Downgrades, Price Target, Analyst Ratings
Atlantic Equities analyst James Mainwaring downgrades Illumina (NASDAQ:ILMN) from Overweight to Neutral and announces $390 price target.
Canaccord Genuity Upgrades Illumina to Buy, Announces $445 Price Target
31 Mar 21
News, Upgrades, Price Target, Analyst Ratings
Canaccord Genuity analyst Max Masucci upgrades Illumina (NASDAQ:ILMN) from Hold to Buy and announces $445 price target.
Despite FTC Challenges Opposing Grail Acquisition, Illumina Committed To Pursue Deal: Report
31 Mar 21
Biotech, Government, M&A, News, Health Care, General
The Federal Trade Commission (FTC) is reportedly looking to stop Illumina Inc’s (NASDAQ: ILMN) $7.1 billion proposed acquisition of Grail Inc.
Illumina Issues Press Release Highlighting FTC Challenge Of Acquisition Of GRAIL, Says 'Disagrees, Opposes'
30 Mar 21
News, Legal
Illumina, Inc. (NASDAQ:ILMN), today announced that it disagrees with, and will oppose, the U.S. Federal Trade Commission (FTC)’s challenge to its previously announced acquisition of GRAIL, a pre-commercial company
Ark Funds, Illumina Invest In SomaLogic SPAC Deal: What Investors Should Know
29 Mar 21
Biotech, M&A, News, IPOs, ETFs, General
A leader in the proteomics field is going public with a SPAC deal announced Monday.
From Smart Toothbrushes To Reimagined Tampons: RBC's 'Imagine 2025' Is Ahead Of Schedule
28 Mar 21
Analyst Color, Health Care, Psychology, Analyst Ratings, Tech, General
More than two years ago, RBC Capital Markets analyst Nik Modi published a white paper titled, "Imagine 2025 - The Consumer Edition," that explored how technology can solve some of today's problems.
What Scott Gottlieb Thinks About The Heated Exchange Between Anthony Fauci And Rand Paul
19 Mar 21
Health Care, Media, General
Former FDA Commissioner Dr. Scott Gottlieb commented on the heated mask debate between Chief Medical Advisor to the President Dr. Anthony Fauci and Republican Sen. Rand Paul, noting "both made valid points."

Press releases

Pro users get this 30m faster
IDbyDNA Shares Insights on Role of Metagenomics for Tracking COVID-19 on New Illumina Podcast
9 Apr 21
Press Releases
SAN FRANCISCO, April 9, 2021 /PRNewswire-PRWeb/ -- Today, IDbyDNA, the company revolutionizing the use of metagenomics to improve health by decoding the unknown, is being featured on two episodes of the new Illumina,
IDbyDNA Shares Insights on Role of Metagenomics for Tracking COVID-19 on New Illumina Podcast
9 Apr 21
Metagenomics Innovator Featured on New Series about Role of Genomics for Managing Global Pandemics SAN FRANCISCO (PRWEB) April 09, 2021 Today, IDbyDNA, the company revolutionizing the use of metagenomics to improve
Thinking about trading options or stock in Illumina, BP, General Motors, Norwegian Cruise Line, or Wynn Resorts?
6 Apr 21
Opinion, Press Releases
NEW YORK, April 6, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ILMN, BP, GM, NCLH, and WYNN.
Quantitative Scientific Solutions Joins DNA Storage Alliance
6 Apr 21
Press Releases
Northern Virginia-based Technology Company Brings Deep Subject Matter Expertise to Help Advance the Adoption of DNA Data Storage to Meet Growing Demand for the Storage of Valuable Digital Information Quantitative
Illumina Announces Preliminary Revenue for First Quarter Fiscal Year 2021
5 Apr 21
Press Releases
Updates Fiscal Year 2021 Revenue Guidance Illumina, Inc. (NASDAQ:ILMN) today announced preliminary revenue for the first quarter of fiscal year 2021 and updated its fiscal year 2021 revenue guidance. Subject to
Illumina Committed to Pursuing GRAIL Acquisition to Accelerate Access to Breakthrough Multi-Cancer Early Detection Blood Test
30 Mar 21
Press Releases
Illumina, Inc. (NASDAQ:ILMN), today announced that it disagrees with, and will oppose, the U.S. Federal Trade Commission (FTC)'s challenge to its previously announced acquisition of GRAIL, a pre-commercial company
Illumina Announces Board Changes
18 Mar 21
Press Releases
Jay Flatley to step down from the Board; John W. Thompson to be appointed new Chair Illumina, Inc. (NASDAQ:ILMN) (the "Company") today announced that Jay Flatley has decided to step down from the Board of Directors and
Geneseeq Inks Deal with Illumina to Develop and Commercialize Comprehensive Cancer In-vitro Diagnostic NGS Kit in China
16 Mar 21
Press Releases
TORONTO, March 16, 2021 /CNW/ - Next-generation sequencing (NGS)-based precision oncology provider Geneseeq Technology Inc. ("Geneseeq"), will collaborate with Illumina, Inc. (NASDAQ:ILMN) ("Illumina") to
Geneseeq Inks Deal with Illumina to Develop and Commercialize Comprehensive Cancer In-vitro Diagnostic NGS Kit in China
16 Mar 21
Press Releases
TORONTO, March 16, 2021 /PRNewswire/ - Next-generation sequencing (NGS)-based precision oncology provider Geneseeq Technology Inc. ("Geneseeq"), will collaborate with Illumina, Inc. (NASDAQ:ILMN)
Iridia Raises $24 Million in Series B Funding
16 Mar 21
News, Financing, Press Releases
SAN DIEGO, March 16, 2021 (GLOBE NEWSWIRE) -- Iridia™, Inc., a pioneer in fully integrated DNA-based memory chips, today announced that it has closed its Series B financing at a total of $24 million. The round,
Illumina and Harvard Pilgrim Health Care Real-World Evidence Study Demonstrates Cost-Effectiveness of Offering NIPT to All Pregnant Women
11 Mar 21
Press Releases
Illumina, Inc. (NASDAQ:ILMN), along with researchers at the University of Colorado and Harvard Pilgrim Health Care (HPHC), reported study results evaluating the impact of an innovative risk-sharing agreement that opened
Illumina and R-Pharm Secure Registration for Two Complete IVD Sequencing Platforms in Russia
5 Mar 21
Press Releases
Illumina, Inc.'s (NASDAQ:ILMN) NextSeq™ 550Dx platform and associated reagent kits received medical device registration in Russia, as have reagents for the MiSeq™Dx which was approved previously as a
Myriad Genetics Joins Forces with Intermountain Precision Genomics for a Comprehensive Offering of Germline and Somatic Tumor Testing Services
2 Mar 21
Health Care, Press Releases
SALT LAKE CITY, March 02, 2021 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in genetic testing and precision medicine, today announced a new strategic precision oncology collaboration with
Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2020
11 Feb 21
Press Releases
Illumina, Inc. (NASDAQ:ILMN) today announced its financial results for the fourth quarter and fiscal year 2020. Record fourth quarter revenue reflects a strong close to 2020: Revenue of $953 million, an increase of
Illumina, Inc. to Host Earnings Call
11 Feb 21
Earnings, News, Press Releases
NEW YORK, NY / ACCESSWIRE / February 11, 2021 / Illumina, Inc. (NASDAQ:ILMN) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on February 11, 2021 at 5:00 PM Eastern Time.To
Illumina to Webcast Upcoming Investor Conference Presentations
10 Feb 21
Press Releases
Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conferences and invited investors to participate via webcast. SVB Leerink Annual Global Healthcare Conference
Illumina Accelerator Invests in Nine Genomics Startups for Second Global Cycle
8 Feb 21
Press Releases
Commitment from Cornerstone Investor LifeArc to Advance Genomics Startups in the UK Feb. 8, 2021 -- Illumina, Inc. (NASDAQ:ILMN) has selected nine new genomics companies to join the second global funding cycle of
Illumina Supports National Program to Evaluate Potential of Comprehensive Genomic Profiling in Late Stage Cancer Real-World Setting Across Belgium
4 Feb 21
Press Releases
Study will measure the impact of comprehensive genomic profiling on access to, and uptake of, personalized medicines and on clinical outcomes for patients February 4, 2021 -- Today, Illumina, Inc. (NASDAQ:ILMN)
Illumina and Sequoia Capital China Partner to Launch Genomics Incubator in China
31 Jan 21
Press Releases
Partners Announce Sequoia Capital China Intelligent Healthcare Genomics Incubator, Powered by Illumina January 31, 2021—Illumina, Inc. (NASDAQ:ILMN), the global leader in DNA sequencing and array-based technologies,
Illumina to Announce Fourth Quarter & Full Year 2020 Financial Results on Thursday, February 11, 2021
25 Jan 21
Press Releases
Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for the fourth quarter and full year 2020 following the close of market on Thursday, February 11, 2021. On the same day, at 2:00 pm Pacific Time